Innovax-ILT (live cell frozen vaccine against Marek’s disease and avian infectious laryngotracheitis)
Ingredients: one dose of the vaccine contains at least 2248 BTO of live recombinant turkey herpesvirus strain HVT / ILT-138 serotype 3 composed of genes of infectious laryngotracheitis virus.
The vaccine contains Gentamycin residues.
Pharmaceutical form: frozen cell suspension.
Method of administration and dosage forms: administer 0.2 ml of the product per head subcutaneously in the neck area.
Inovo vaccine is injected on the 18th day of embryo development at a dose of 0.05 ml / egg.
Packaging: vaccine: sealed cryogenic type I glass vials (according to the European Pharmacopoeia) containing a cell suspension of 1,000, 2,000, 3,000, 4,000 or 5,000 doses of the vaccine.
Nobilis® Diluent CA solvent: polyethylene bags (according to European Pharmacopoeia) of 200, 400, 500, 600, 800, 1000 and 1200 ml, sealed with rubber stopper and cap.
Storage and transportation conditions: Vials to be stored in a container with liquid nitrogen.
Solvent to be stored at room temperature (15-25 ºС).
Containers to be stored in a clean, dry place, in an upright position in a well ventilated room, separated from the incubation and poultry house.